Trial Profile
A Randomized, Open-label, Crossover Study to Demonstrate Bioequivalence Between 6 x 2-mg Tablets of Perampanel and a Single 12-mg Tablet of Perampanel in Healthy Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 10 May 2012
Price :
$35
*
At a glance
- Drugs Perampanel (Primary)
- Indications Epilepsy; Migraine; Multiple sclerosis; Neuropathic pain
- Focus Pharmacokinetics
- Sponsors Eisai Inc
- 21 Jul 2011 New trial record